– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and clear clinical proof of concept, including confirmed responses…
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented today as an oral presentation at 2025 AACR-NCI-EORTC…
October 23, 2025 13:48 ET | Source: Neocis MIAMI, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Neocis®, the leader in robotic-assisted…
AUSTIN, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The award-winning film An Inconvenient Study has been seen by millions following its…
October 23, 2025 13:08 ET | Source: Progyny, Inc. NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq:…
EdgeAI recognized for pioneering edge computing solutions at APAC Finals in Singapore. October 23, 2025 13:00 ET | Source: EdgeAI…
Shenzhen, China , Oct. 23, 2025 (GLOBE NEWSWIRE) -- Have you ever been held back by a lead-acid battery? On an…
Sword Group is pleased to announce the acquisition of Full On Net, a technology consulting firm headquartered in Madrid, Spain,…
October 22, 2025 17:59 ET | Source: HearAdvisor Rockford, Il, Oct. 22, 2025 (GLOBE NEWSWIRE) -- HearAdvisor, an independent audio…
October 22, 2025 16:30 ET | Source: CVRx, Inc. MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX)…